RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

2D Structure

Could not render structureView on PubChem

3D Structure

No structure available on PubChemSearch PubChem

Chemical Identifiers

SMILES:

CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3

InChI Key:

XFCLJVABOIYOMF-QPLCGJKRSA-N

ClinicalTrials.gov PubMed

Clinical Development by Virus4

Zaire ebolavirus

EBOV

Target: Human Human ER

Preclinical

Preclinical

Phase 2

Phase 3

Approved

Middle East respiratory syndrome-related coronavirus

MERS-CoV

Target: Human Human ER

Preclinical

Preclinical

Phase 2

Phase 3

Approved

Severe acute respiratory syndrome-related coronavirus

SARS-CoV

Target: Human Human ER

Preclinical

Preclinical

Phase 2

Phase 3

Approved

Lujo mammarenavirus

LUJV

Target: Human Human ER

Preclinical

Preclinical

Phase 2

Phase 3

Approved